L & S Advisors Inc - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 455 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.2%.

Quarter-by-quarter ownership
L & S Advisors Inc ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,732,719
+45.3%
14,294
+37.3%
0.25%
+56.6%
Q2 2023$1,192,611
+18.3%
10,414
+42.4%
0.16%
+12.8%
Q1 2023$1,008,226
-23.3%
7,315
-27.9%
0.14%
-42.0%
Q4 2022$1,314,460
+3.3%
10,144
-11.8%
0.24%
+8.5%
Q3 2022$1,272,000
-58.0%
11,507
-35.2%
0.22%
-36.2%
Q4 2020$3,026,000
+120.9%
17,751
+81.9%
0.35%
+86.7%
Q3 2020$1,370,000
-25.9%
9,756
-15.4%
0.19%
-31.9%
Q2 2020$1,848,000
+53.5%
11,526
-6.4%
0.28%
+21.6%
Q1 2020$1,204,000
-32.4%
12,310
-10.8%
0.23%
-0.4%
Q4 2019$1,781,000
+69.9%
13,803
-0.8%
0.23%
+55.1%
Q3 2019$1,048,000
-46.0%
13,908
+8.8%
0.15%
-42.6%
Q2 2019$1,942,000
+21.7%
12,783
-4.6%
0.26%
+19.1%
Q1 2019$1,596,000
+13.0%
13,393
+3.5%
0.22%
-18.9%
Q4 2018$1,412,000
-27.8%
12,938
+6.8%
0.26%
+4.7%
Q3 2018$1,956,000
+26.4%
12,113
+3.4%
0.25%
-3.1%
Q2 2018$1,548,000
+76.9%
11,715
-0.8%
0.26%
+56.3%
Q1 2018$875,000
+84.2%
11,813
+38.4%
0.17%
+128.8%
Q4 2017$475,0008,5350.07%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Casdin Capital, LLC 1,010,330$122,472,20313.56%
Finepoint Capital LP 145,357$17,620,1768.78%
Avoro Capital Advisors LLC 4,025,000$487,910,5007.61%
Saturn V Capital Management LP 118,401$14,352,5696.01%
Ghost Tree Capital, LLC 150,000$18,183,0005.98%
Ikarian Capital, LLC 3,673$44,524,1065.36%
ACUTA CAPITAL PARTNERS, LLC 550$7,580,6505.08%
Eagle Health Investments LP 174,212$21,117,9794.65%
Boxer Capital, LLC 600,000$72,732,0003.87%
GREAT POINT PARTNERS LLC 165,200$20,025,5443.65%
View complete list of SAREPTA THERAPEUTICS INC shareholders